Reversible cardiotoxicity with tyrosine kinase inhibitors.
Francis J, Ahluwalia MS, Wetzler M, Wang E, Paplham P, Smiley S, McCarthy PL, Cohen IL, Spangenthal E, Battiwalla M.
Francis J, et al.
Clin Adv Hematol Oncol. 2010 Feb;8(2):128-32.
Clin Adv Hematol Oncol. 2010.
PMID: 20386534
No abstract available.